Please login to the form below
Sandoz expands into Japan with €400m Aspen deal
Will gain presence in third largest generics market in the world
Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture
Will pay $100m upfont and pledges $210m in milestone payments
Takeda divests over-the-counter and prescription drugs to Stada for $660m
Japanese pharma said it has plans to divest $10bn in non-core assests
AstraZeneca launches $1bn Chinese investment fund
AZ is among the top investors in the country with a strong market presence
Sanofi settles Lemtrada dispute with Genzyme investors for $315m
The MS drug has been in decline amid increased market competition
Amgen buys BeiGene stake for $2.7bn to aid push into China
China's oncology market forecast to nearly double in size by 2026
Novo bolstered by new diabetes, obesity products
Danish drug-maker has now raised its full-year sales forecast
BMS’ Opdivo stalls in Q3, but overall figures still top expectations
Group sales rose 6% to $6bn in the third quarter
GSK boosts outlook thanks to strong respiratory and vaccine sales
Key Q3 drivers include Shingrix vaccine and asthma drug Nucala
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
Dupixent gains can’t keep Sanofi on a growth trackReports fall in Q3 sales despite growth of immunology drug
-
Pfizer raises forecast following growth of biopharma businessOn the flip-side company reported decline in Upjohn generics division
-
Merck CFO: we’re not only about KeytrudaHighlighted the continued growth of other key cancer drugs
-
Roche moving closer to approval of Spark takeover; reportAntitrust authorities in both US and UK look likely to end delay
-
UK government raises concerns about Illumina’s $1.2bn takeover of PacBio CMA concludes the merger will result in loss of market competition
-
AZ reports growth again in Q3, driven by oncology and China sales Company has also returned to growth in Europe
-
Novartis grows in Q3 thanks to stellar performance of key drugsCosentyx, Entresto and Zolgensma topped drive sales growth
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director, Medical Education
-
Salary TBC
- OTC / Consumer Health PR Account Director
-
profit share, pens, life assurance more
-
Account Supervisor
-
Salary TBC
- Senior Editor - Medical Communications - South East - Buckingham...
-
Highly competitive salary &package
-
Account Executive
-
Salary TBC
- Scientific Director - Medical Communications - Berkshire
-
Excellent package on offer
-
Senior Medical Writer
-
Salary TBC
- Entry Level Editorial Assistant – Medical Education –Buckinghams...
-
Highly Competitive
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
- Moving annual total (MAT)
- Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture
- Key success factor (KSF)
- Genital herpes vaccine candidate heads for human studies
- China okays Green Valley’s algae-based drug for Alzheimer’s drug
- The first of many celebrations for Lucid Group at Middlesex House
- New faces at creative digital agency earthware
- Merck claims first-ever okay for Ebola vaccine, in Europe
- UK biotech Evgen craters on failed stroke trial
- BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer
- Otsuka presses on with Alzheimer’s agitation drug
- Pharmaceutical innovation in the APAC region
PMHub
BASTARD . LONDON
BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...
Latest intelligence
- Pharmaceutical innovation in the APAC region
- A first-of-its-kind study paints a vivid picture of the APAC region’s future...
- Patient journey mapping: exploring the clinical and the emotional journey
- By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
- Precision medicine at Blue Latitude Health
- At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...
Quick links
Infographics
